Bristol-Myers Squibb agrees to acquire Celgene in a $74 billion cash-and-stock deal, creating a pharmaceutical giant that will rival the world’s biggest drugmakers https://t.co/MItrtQ6OWE
— Bloomberg (@business) January 3, 2019
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.